BLUE OWL CAPITAL INC. annual report, FY2023

Blue Owl Capital Inc. — 2023 Form 10-K Summary

Reporting period: Fiscal year ended December 31, 2023. This is an annual filing; the supplied text does not provide a clear standalone fourth-quarter income statement. Blue Owl is a global alternative asset manager operating across Credit, GP Strategic Capital and Real Estate, with one reportable segment. Its Class A shares trade on the NYSE under OWL.

Business context and operating scale

  • Year-end AUM was $165.7 billion, including $102.7 billion of fee-paying AUM (FPAUM). Credit accounted for $84.6 billion of AUM, GP Strategic Capital $54.2 billion and Real Estate $26.9 billion.
  • Approximately 92% of 2023 management fees came from Permanent Capital vehicles. Management reported $14.5 billion of AUM not yet paying fees, which could generate approximately $200 million of annualized management fees once deployed or applicable fee holidays expire.
  • Blue Owl completed the Par Four CLO-management acquisition in August 2023 and the Cowen Healthcare Investments (CHI) acquisition in December 2023. CHI added approximately $1 billion of AUM and expanded the firm into biopharmaceutical and healthcare investments.

Financial performance and liquidity

Metric20232022
GAAP revenue, net$1.732 billion$1.370 billion
Management fees, net$1.527 billion$1.212 billion
Consolidated net income (loss)$220.8 million$(40.2) million
Net income (loss) attributable to Blue Owl$54.3 million$(9.3) million
Fee-Related Earnings (non-GAAP)$997.7 million$800.1 million
Distributable Earnings (non-GAAP)$927.8 million$742.8 million
Cash provided by operating activities$949.1 million$728.4 million
  • Revenue increased 26% year over year, primarily from Credit fundraising and deployment, including higher Part I Fees, and growth in Real Estate. Part I Fees rose to $387.3 million from $234.0 million; management attributed part of the increase to higher interest rates.
  • FRE increased about 25%; FRE expenses rose to $652.1 million from $529.3 million as headcount and occupancy costs grew. FRE was about 60% of FRE revenue in 2023 versus about 61% in 2022. These are non-GAAP measures and are not substitutes for GAAP results or liquidity measures.
  • Year-end cash and cash equivalents were $104.2 million. The $1.55 billion revolving facility had $205 million drawn and approximately $1.338 billion available, after reductions for letters of credit. Management said liquidity and fee cash flows should meet anticipated working-capital needs for at least 12 months.
  • Year-end debt principal totaled $1.715 billion: $59.8 million of 2028 Notes, $700 million of 2031 Notes, $400 million of 2032 Notes, $350 million of 2051 Notes and $205 million drawn on the revolver. GAAP debt carrying value, net, was $1.681 billion. Fixed-rate notes bear coupons of 3.125% to 7.397%; the revolver is SOFR-based.
  • Net cash used in financing activities was $795.0 million, mainly reflecting distributions to Common Unit holders and Class A dividends. Blue Owl paid $247.9 million in Class A dividends during 2023. Total assets were $8.818 billion and total liabilities $3.540 billion at year-end.

Changes, outlook, risks and unusual items

  • AUM grew from $138.2 billion to $165.7 billion. Contributions included $15.8 billion of new capital raised, $6.0 billion from changes in debt, $9.0 billion from appreciation and other changes, and acquisition additions; distributions partially offset growth. FPAUM rose from $88.8 billion to $102.7 billion.
  • GAAP earnings improved from a loss to profit. Performance revenues declined to $3.6 million from $12.2 million, while interest expense increased to $75.7 million from $60.1 million. A $14.1 million warrant-liability loss and a $6.4 million earnout-liability loss affected 2023 results. Compensation expense fell overall, partly due to lower acquisition-related compensation, while recurring employee compensation and headcount increased.
  • Amortization of intangible assets was $300.3 million, including accelerated write-off of $72.4 million in remaining trademark value after corporate actions. The CHI acquisition resulted in a $6.0 million bargain-purchase gain. The second Oak Street earnout trigger was achieved in January 2024.
  • For fiscal 2024, management set a target annual dividend of $0.72 per Class A share ($0.18 quarterly), subject to Board approval each quarter. The filing says the fixed dividend will be reassessed annually and may be changed or eliminated. The fourth-quarter 2023 dividend was $0.14 per share, payable March 5, 2024.
  • Management described improving loan-market activity late in 2023, greater repayments and redeployment into higher-yielding opportunities, and continued deployment and fundraising opportunities. It also noted muted Real Estate valuations and transactions amid higher rates, cost inflation, vacancy and supply concerns. No formal revenue or earnings forecast is provided; the approximately $200 million of potential annualized fees from non-fee-paying AUM is conditional on deployment or fee-holiday expiry.
  • Key risks include persistent high interest rates and inflation, weaker fundraising or deployment, credit losses and valuation uncertainty in illiquid investments, leverage at products and the company, redemption pressure in non-traded products, competition, regulatory change and conflicts of interest. The Tax Receivable Agreement could require substantial payments: management estimated approximately $1.0 billion under stated assumptions, including $716.2 million thereafter. Payments may vary, and acceleration could be substantial.
  • The company reported no material cybersecurity incident in 2023 and no pending legal proceeding expected to have a material impact on the financial statements. Management and KPMG concluded that internal control over financial reporting was effective as of year-end.

Important facts for investors to verify

  • Reconcile GAAP earnings attributable to Blue Owl with FRE and Distributable Earnings, including the exclusions and assumptions behind these non-GAAP measures.
  • Track whether the $14.5 billion of AUM not yet paying fees is deployed or becomes fee-paying, and whether the associated potential fee increase is realized.
  • Review the TRA estimate, timing and funding requirements, including possible acceleration and the effect on cash available for dividends.
  • Assess debt maturities, revolver utilization and floating-rate exposure, alongside distributions, dividends and acquisition-related cash needs.
  • Examine valuation assumptions and realized performance for private investments and products; the filing cautions that unrealized values and historical returns may not be realized or repeated.
  • Monitor acquisition integration and growth costs, regulatory developments, non-traded product redemption activity, and the impact of market conditions on fundraising and deployment.